Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 73Carcinoma, Hepatocellular 67Stomach Neoplasms 52Pancreatic Neoplasms 40Rectal Neoplasms 30Colonic Neoplasms 30Neoplasms 21Liver Neoplasms 20Esophageal Neoplasms 19Neoplasm Metastasis 16Cholangiocarcinoma 16Esophageal Squamous Cell Carcinoma 14Gallbladder Neoplasms 12Biliary Tract Neoplasms 12Lung Neoplasms 10Gastrointestinal Neoplasms 7Adenocarcinoma Of Esophagus 7Ovarian Neoplasms 6Prostatic Neoplasms 5Neoplasms by Site 5Bile Duct Neoplasms 5Adenocarcinoma 5Polyps 4Neoplasms by Histologic Type 4Melanoma 4Hematologic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Adenoma 4Recurrence 3

Interventions

Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Locally Advanced Resectable Rectal Cancer × Gastrointestinal × Clear all
NCT07454720 2026-05-05

A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 2/3 Recruiting
165 enrolled
Gastrointestinal

Locally Advanced Resectable Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡